Agents and Actions

, Volume 2, Issue 4, pp 170–175 | Cite as

Distribution and pharmacokinetics of14C-toxiferine in rats

  • P. G. Waser
  • J. Reller
Research Reports


The distribution of14C-toxiferine in rats was investigated using a combustion method in combination with whole-body autoradiograms at different time intervals after intravenous injection. The distribution is essentially the same as those of other non-depolarizing curare drugs. In contrast to the short-acting N-N′-diallyl-bis-nor-toxiferine (Alcuronium) only minor periodic shifts within the different compartments of the organism, little binding to mucopolysaccharides in connective tissue and cartilage and slow elimination were found. This may explain the long paralytic action of toxiferine.


Connective Tissue Intravenous Injection Mucopolysaccharide Curare Drug Slow Elimination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    E. N. Cohen, A. Corbascio andG. Fleischli,The Distribution and Fate of d-Tubocurarine J. Pharmac. exp. Ther.147, 120–129 (1965).Google Scholar
  2. [2]
    E. N. Cohen, H. W. Brewer andD. Smith,The Metabolism and Elimination of d-Tubocurarine-H 3, Anesthesiology28, 309–317 (1967).PubMedGoogle Scholar
  3. [3]
    F. Kalberer,A New Method of Macroautoradiography, Advances in Tracer Methodology, vol. 3 (Plenum Press, New York 1960), p. 139–147.Google Scholar
  4. [4]
    F. Kalberer andJ. Rutschmann,Eine Schnellmethode zur Bestimmung von Tritium, Radiokohlenstoff und Radioschwefel in beliebigem organischem Probenmaterial mittels des Flüssigkeits-Scintillationszählers, Helv. chim. Acta44, 1956–1966 (1961).CrossRefGoogle Scholar
  5. [5]
    U. Lüthi,Verteilung und Metabolismus von curarisierenden Substanzen, Bull. schweiz. Akad. med. Wiss.22, 501–510 (1966).Google Scholar
  6. [6]
    U. Lüthi andP. G. Waser,Verteilung und Metabolismus von 14 C-Carbachol bei atropinisierten Katzen. Arch. int. Pharmacodyn.,167, 369–402 (1967).PubMedGoogle Scholar
  7. [7]
    P. G. Waser,Autoradiographic Studies of Motor Endplates with toxiferine, in:Preparation and Biomedical Application of Labelled Molecules (publ. by Euratom 2200e, Brussels 1964), p. 365–371.Google Scholar
  8. [8]
    P. Waser, H. Schmid andK. Schmid,Resorption, Verteilung und Ausscheidung von Radio-Calebassen-Curarin bei Katzen, Arch. int. Pharmacodyn.96, 386–405 (1954).PubMedGoogle Scholar
  9. [9]
    P. G. Waser andU. Lüthi,Verteilung, Metabolismus und Elimination von 3 H-Diallylnor-Toxiferin (Alloferin) bei Katzen, Helv. physiol. Acta24, 259–273 (1966).Google Scholar
  10. [10]
    O. Wassermann,Studies on the Pharmacokinetics of Bis-Quaternary Ammonium Compounds; II. Autoradiographic Studies on the Distribution of 3 H-Hexamethonium in Mice, Naunyn-Schmiedebergs Arch. Pharmak.270, 419–427 (1971).CrossRefGoogle Scholar

Copyright information

© Birkhäuser-Verlag 1972

Authors and Affiliations

  • P. G. Waser
    • 1
  • J. Reller
    • 1
  1. 1.Department of PharmacologyUniversity of ZürichZürichSchweiz

Personalised recommendations